|
2024
|
Invention
|
Engineered safety in cell therapy.
The present disclosure relates to compositions and methods fo... |
|
|
Invention
|
Rapamycin and cell therapy.
Embodiments of the present disclosure relate to compositions and met... |
|
|
Invention
|
Use of chimeric antigen receptor modified cells to treat cancer.
The present disclosure relates ... |
|
2023
|
Invention
|
Nanobody target msln and uses in chimeric antigen receptor cell therapy.
The present disclosure ... |
|
|
Invention
|
Nanobody target gcc and uses in chimeric antigen receptor cell therapy. The present disclosure de... |
|
|
Invention
|
Managing side effects in t cell therapy.
The present disclosure relates to compositions and meth... |
|
|
Invention
|
Recombinant viral particle for gene and/or cellular therapy. The present disclosure relates to sy... |
|
|
Invention
|
Vaccine and uses thereof in cell therapy.
The present disclosure relates to compositions and met... |
|
|
Invention
|
Enhanced chimeric antigen receptor cells in hypoxic tumor microenvironment.
Embodiments of the p... |
|
2022
|
Invention
|
Cell therapy activating lymphocyte in tme.
The present disclosure relates to compositions and me... |
|
|
Invention
|
Nanobody target gcc and uses in chimeric antigen receptor cell therapy. The compositions and meth... |
|
|
Invention
|
Recombinant viral particle for gene and/or cellular therapy.
The present disclosure relates to s... |
|
|
Invention
|
Modified cell targeting tumor ecm and cellular therapy thereof.
Embodiments relate to a modified... |
|
|
Invention
|
Modified chimeric antigen receptor and use thereof.
Embodiments of the present disclosure relate... |
|
|
Invention
|
Modified cell expressing therapeutic agent and uses thereof.
Compositions and methods for enhanc... |
|
|
Invention
|
Humanized antl-cd19 antibody and use thereof with chimeric antigen receptor.
Embodiments herein ... |
|
|
Invention
|
Vaccine and uses thereof in cell therapy. The present disclosure relates to compositions and meth... |
|
|
Invention
|
Car cells and polyspecific binding molecules for treating solid tumor.
The compositions and meth... |
|
2021
|
Invention
|
Modified cell and use thereof in gene and cell therapy. The present disclosure describes composit... |
|
|
Invention
|
Fusion protein enhancing cell therapy.
The present disclosure relates to a fusion protein and us... |
|
|
Invention
|
Fusion protein enhancing cell therapy. The present disclosure relates to a fusion protein and use... |
|
|
Invention
|
Reducing immune inhibition induced by siglec-15. The present disclosure relates to a modified cel... |
|
|
Invention
|
Cell/gene therapies targeting mage-a4 peptide.
The present disclosure relates to compositions an... |
|
|
Invention
|
Cell/gene therapies targeting mage-a4 peptide. The present disclosure relates to compositions and... |
|
|
Invention
|
Anti-gcc antibody and car thereof for treating digestive system cancer. The present disclosure re... |
|
|
Invention
|
System and method for gene and/or cellular therapy.
The present disclosure relates to a system f... |
|
|
Invention
|
Polyspecific binding molecules and their use in cell therapy.
The present disclosure relates to ... |
|
|
Invention
|
Polyspecific binding molecules and their use in cell therapy. in vivoin vitroin vitro. In embodim... |
|
|
Invention
|
Chimeric antigen receptor (car) and t cell receptor (tcr) modified t cells. The present disclosur... |
|
|
Invention
|
Chimeric antigen receptor cells for treating solid tumor. The compositions and methods described ... |
|
|
Invention
|
Engineered safety in cell therapy. The present disclosure relates to compositions and methods for... |
|
2020
|
Invention
|
Reducing immune tolerance induced by pd-l1. The present disclosure relates to compositions and me... |
|
|
Invention
|
Nk cell expansion and uses thereof.
The present disclosure relates to compositions and methods f... |
|
|
Invention
|
Modified tcr and uses thereof. Embodiments relate to a modified cell engineered to comprise a mod... |
|
|
Invention
|
Modified cell with enhanced functionality and cellular therapy thereof. Embodiments relate to a m... |
|
|
Invention
|
Presenting cell and use thereof in cell therapy.
The present disclosure relates to compositions ... |
|
|
Invention
|
Use of chimeric antigen receptor modified cells to treat cancer. The present disclosure relates t... |
|
|
Invention
|
Coupled redirected cells and uses thereof.
The present disclosure relates to compositions and me... |
|
|
Invention
|
Modulating t cell function and response.
The present disclosure describes a method of producing ... |
|
|
Invention
|
Activation of apc in immunotherapy. Embodiments relate to compositions and methods for treating s... |
|
|
Invention
|
Inducible dominant negative pd-1 and uses in adoptive cell therapy. Embodiments relate to a modif... |
|
|
Invention
|
Modified cell expansion and uses thereof.
The present disclosure relates to compositions and met... |
|
|
Invention
|
Modified cell expansion and uses thereof. The present disclosure relates to compositions and meth... |
|
|
Invention
|
Modified cell expansion and uses thereof. in vivo in vitro in vitro. For example, a method of enh... |
|
2019
|
Invention
|
Modified cell with enhanced migration capability. Embodiments relate to a modified T cell compris... |
|
|
Invention
|
Modified cell expressing therapeutic agent and uses thereof. Compositions and methods for enhanci... |
|
|
G/S
|
Stem cells for medical purposes; preparations containing cells; cellular pharmaceutical preparati... |
|
|
Invention
|
Chimeric antigen receptor cells for treating solid tumor.
The compositions and methods described... |
|
2018
|
G/S
|
Pharmaceutical research and development; Research and development in the pharmaceutical and biote... |
